Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646.
CAS PubMed Article Google Scholar
Wang YA, Li XL, Mo YZ, Fan CM, Tang L, Xiong F, et al. Effects of tumor metabolic microenvironment on regulatory T cells. Mol Cancer. 2018;17(1):168.
CAS PubMed PubMed Central Article Google Scholar
Liu F, Qin L, Liao Z, Song J, Yuan C, Liu Y, et al. Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma. Exp Hematol Oncol. 2020;9:10.
CAS PubMed PubMed Central Article Google Scholar
Fu T, Dai LJ, Wu SY, Xiao Y, Ma D, Jiang YZ, et al. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J Hematol Oncol. 2021;14(1):98.
PubMed PubMed Central Article Google Scholar
Dunn G, Bruce A, Ikeda H, Old L, Schreiber R. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3(11):991–8.
CAS PubMed Article Google Scholar
Wu W, Liu Y, Zeng S, Han Y, Shen H. Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes. J Hematol Oncol. 2021;14(1):160.
CAS PubMed PubMed Central Article Google Scholar
Baitsch L, Baumgaertner P, Devêvre E, Raghav S, Legat A, Barba L, et al. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. J Clin Invest. 2011;121(6):2350–60.
CAS PubMed PubMed Central Article Google Scholar
Wherry E. T cell exhaustion. Nat Immunol. 2011;12(6):492–9.
CAS PubMed Article Google Scholar
Yi M, Niu M, Zhang J, Li S, Zhu S, Yan Y, et al. Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers. J Hematol Oncol. 2021;14(1):146.
CAS PubMed PubMed Central Article Google Scholar
Li Y, Zhang Y, Cao G, Zheng X, Sun C, Wei H, et al. Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors. J Hematol Oncol. 2021;14(1):100.
PubMed PubMed Central Article CAS Google Scholar
Swann J, Smyth M. Immune surveillance of tumors. J Clin Invest. 2007;117(5):1137–46.
CAS PubMed PubMed Central Article Google Scholar
Yang Z, Guo J, Weng L, Tang W, Jin S, Ma W. Myeloid-derived suppressor cells-new and exciting players in lung cancer. J Hematol Oncol. 2020;13(1):10.
CAS PubMed PubMed Central Article Google Scholar
Qiu Y, Chen T, Hu R, Zhu R, Li C, Ruan Y, et al. Next frontier in tumor immunotherapy: macrophage-mediated immune evasion. Biomark Res. 2021;9(1):72.
PubMed PubMed Central Article Google Scholar
Hao Z, Li R, Wang Y, Li S, Hong Z, Han Z. Landscape of myeloid-derived suppressor cell in tumor immunotherapy. Biomark Res. 2021;9(1):77.
PubMed PubMed Central Article Google Scholar
Wang L, He T, Liu J, Tai J, Wang B, Chen Z, et al. Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment. Exp Hematol Oncol. 2021;10(1):31.
CAS PubMed PubMed Central Article Google Scholar
Zhu S, Yi M, Wu Y, Dong B, Wu K. Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies. Exp Hematol Oncol. 2021;10(1):60.
CAS PubMed PubMed Central Article Google Scholar
Xu T, Yu S, Zhang J, Wu S. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers. J Hematol Oncol. 2021;14(1):181.
CAS PubMed PubMed Central Article Google Scholar
Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775–87.
CAS PubMed Article Google Scholar
Zou L, Barnett B, Safah H, Larussa V, Evdemon-Hogan M, Mottram P, et al. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 2004;64(22):8451–5.
CAS PubMed Article Google Scholar
Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2001;194(6):847–53.
CAS PubMed PubMed Central Article Google Scholar
Liu M, Liu W, Qin Y, Xu X, Ji S. Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer. Exp Hematol Oncol. 2020;9(1):23.
Leone RD, Powell JD. Metabolism of immune cells in cancer. Nat Rev Cancer. 2020;20(9):516–31.
CAS PubMed PubMed Central Article Google Scholar
Zhang Y, Mao Q, Xia Q, Cheng J, Huang Z, Li Y, et al. Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers. J Hematol Oncol. 2021;14(1):169.
CAS PubMed PubMed Central Article Google Scholar
Lim SA, Wei J, Nguyen T-LM, Shi H, Su W, Palacios G, et al. Lipid signalling enforces functional specialization of Treg cells in tumours. Nature. 2021;591(7849):306–11.
CAS PubMed PubMed Central Article Google Scholar
Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645–51.
CAS PubMed PubMed Central Article Google Scholar
Zappasodi R, Serganova I, Cohen IJ, Maeda M, Shindo M, Senbabaoglu Y, et al. CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours. Nature. 2021;591(7851):652–8.
CAS PubMed PubMed Central Article Google Scholar
Bluestone JA, Anderson M. Tolerance in the age of immunotherapy. N Engl J Med. 2020;383(12):1156–66.
CAS PubMed PubMed Central Article Google Scholar
Gershon R, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology. 1970;18(5):723–37.
CAS PubMed PubMed Central Google Scholar
Gershon R, Kondo K. Infectious immunological tolerance. Immunology. 1971;21(6):903–14.
CAS PubMed PubMed Central Google Scholar
Bullock W, Katz D, Benacerraf B. Induction of T-lymphocyte responses to a small molecular weight antigen. III. T-T cell interactions to determinants linked together: suppression vs. enhancement. J Exp Med. 1975;142(2):275–87.
CAS PubMed Article Google Scholar
Swierkosz JE, Swanborg RH. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis. J Immunol. 1975;115(3):631–3.
Liew F. Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol. 1977;7(10):714–8.
CAS PubMed Article Google Scholar
Schatten S, Granstein R, Drebin J, Greene M. Suppressor T cells and the immune response to tumors. Crit Rev Immunol. 1984;4(4):335–79.
Berendt M, North R. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med. 1980;151(1):69–80.
CAS PubMed Article Google Scholar
Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996;184(2):387–96.
CAS PubMed Article Google Scholar
Ramsdell F, Ziegler S. FOXP3 and scurfy: how it all began. Nat Rev Immunol. 2014;14(5):343–9.
CAS PubMed Article Google Scholar
Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057–61.
留言 (0)